Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
第一作者:
L,Jones
第一单位:
Centre for Reviews and Dissemination, University of York, UK.
作者:
医学主题词
阿司匹林(Aspirin);费用效益分析(Cost-Benefit Analysis);迟效制剂(Delayed-Action Preparations);腹泻(Diarrhea);双嘧达莫(Dipyridamole);药费支出(Drug Costs);药疹(Drug Eruptions);消化不良(Dyspepsia);循证医学(Evidence-Based Medicine);出血(Hemorrhage);人类(Humans);缺血(Ischemia);模型, 经济计量学(Models, Econometric);恶心(Nausea);血小板聚集抑制剂(Platelet Aggregation Inhibitors);研究设计(Research Design);危险因素(Risk Factors);噻氯匹定(Ticlopidine);治疗结果(Treatment Outcome);血管疾病(Vascular Diseases);呕吐(Vomiting)
DOI
10.3310/hta8380
PMID
15461876
发布时间
2025-06-23
基金项目
- 浏览94
Health technology assessment (Winchester, England)
iii-iv, 1-196页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



